Literature DB >> 27584043

An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis.

Amy V Paschall1, Kebin Liu2.   

Abstract

Metastasis is the primary cause of mortality of breast cancer patients. The mechanism underlying cancer cell metastasis, including breast cancer metastasis, is largely unknown and is a focus in cancer research. Various breast cancer spontaneous metastasis mouse models have been established. Here, we report a simplified procedure to establish orthotopic transplanted breast cancer primary tumor and resultant spontaneous metastasis that mimic human breast cancer metastasis. Combined with the bioluminescence live tumor imaging, this mouse model allows tumor growth and progression kinetics to be monitored and quantified. In this model, a low dose (1 x 10(4) cells) of 4T1-Luc breast cancer cells was injected into BALB/c mouse mammary fat pad using a tuberculin syringe. Mice were injected with luciferin and imaged at various time points using a bioluminescent imaging system. When the primary tumors grew to the size limit as in the IACUC-approved protocol (approximately 30 days), mice were anesthetized under constant flow of 2% isoflurane and oxygen. The tumor area was sterilized with 70% ethanol. The mouse skin around the tumor was excised to expose the tumor which was removed with a pair of sterile scissors. Removal of the primary tumor extends the survival of the 4T-1 tumor-bearing mice for one month. The mice were then repeatedly imaged for metastatic tumor spreading to distant organs. Therapeutic agents can be administered to suppress tumor metastasis at this point. This model is simple and yet sensitive in quantifying breast cancer cell growth in the primary site and progression kinetics to distant organs, and thus is an excellent model for studying breast cancer growth and progression, and for testing anti-metastasis therapeutic and immunotherapeutic agents in vivo.

Entities:  

Mesh:

Year:  2016        PMID: 27584043      PMCID: PMC5091834          DOI: 10.3791/54040

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  17 in total

1.  Orthotopic injection of breast cancer cells into the mammary fat pad of mice to study tumor growth.

Authors:  Begüm Kocatürk; Henri H Versteeg
Journal:  J Vis Exp       Date:  2015-02-08       Impact factor: 1.355

2.  MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer.

Authors:  B D Cuevas; A M Winter-Vann; N L Johnson; G L Johnson
Journal:  Oncogene       Date:  2006-03-27       Impact factor: 9.867

3.  CD44 attenuates metastatic invasion during breast cancer progression.

Authors:  Jose I Lopez; Todd D Camenisch; Mark V Stevens; Barbara J Sands; John McDonald; Joyce A Schroeder
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

Review 4.  Modeling metastasis in vivo.

Authors:  Chand Khanna; Kent Hunter
Journal:  Carcinogenesis       Date:  2004-09-09       Impact factor: 4.944

5.  Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.

Authors:  Xiaolin Hu; Kankana Bardhan; Amy V Paschall; Dafeng Yang; Jennifer L Waller; Mary Anne Park; Asha Nayak-Kapoor; Thomas A Samuel; Scott I Abrams; Kebin Liu
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

6.  Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice.

Authors:  H Kwan; V Pecenka; A Tsukamoto; T G Parslow; R Guzman; T P Lin; W J Muller; F S Lee; P Leder; H E Varmus
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

Review 7.  How tumours escape mass destruction.

Authors:  T J Stewart; S I Abrams
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

8.  Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.

Authors:  Suh-Chin J Lin; Kuo-Fen Lee; Alexander Yu Nikitin; Susan G Hilsenbeck; Robert D Cardiff; Aihua Li; Keon-Wook Kang; Steven A Frank; Wen-Hwa Lee; Eva Y-H P Lee
Journal:  Cancer Res       Date:  2004-05-15       Impact factor: 12.701

9.  Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathways.

Authors:  Marta I Gallego; Brian Bierie; Lothar Hennighausen
Journal:  Oncogene       Date:  2003-11-20       Impact factor: 9.867

10.  Mouse models of breast cancer metastasis.

Authors:  Anna Fantozzi; Gerhard Christofori
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

View more
  21 in total

1.  Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy.

Authors:  Wei Xiao; Mohammed L Ibrahim; Priscilla S Redd; John D Klement; Chunwan Lu; Dafeng Yang; Natasha M Savage; Kebin Liu
Journal:  Mol Cancer Res       Date:  2018-11-14       Impact factor: 5.852

2.  Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival.

Authors:  Saraswoti Khadge; Geoffrey M Thiele; John Graham Sharp; Timothy R McGuire; Lynell W Klassen; Paul N Black; Concetta C DiRusso; Leah Cook; James E Talmadge
Journal:  Clin Exp Metastasis       Date:  2018-10-16       Impact factor: 5.150

3.  SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.

Authors:  Priscilla S Redd; Mohammed L Ibrahim; John D Klement; Sarah K Sharman; Amy V Paschall; Dafeng Yang; Asha Nayak-Kapoor; Kebin Liu
Journal:  Cancer Res       Date:  2017-04-05       Impact factor: 12.701

4.  CHPF promotes malignancy of breast cancer cells by modifying syndecan-4 and the tumor microenvironment.

Authors:  Wen-Chieh Liao; Hung-Rong Yen; Chia-Hua Chen; Yin-Hung Chu; Ying-Chyi Song; To-Jung Tseng; Chiung-Hui Liu
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

5.  PEG2000-DBCO surface coating increases intracellular uptake of liposomes by breast cancer xenografts.

Authors:  Daxing Liu; Jules Cohen; Nashaat Turkman
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

6.  Modeling Human Prostate Cancer Metastasis in Mice via Resection of Subcutaneous Allografts.

Authors:  Lauren B Peiffer; Jessica Hicks; Rebecca Y Sosa; Angelo M De Marzo; Karen S Sfanos; Janielle P Maynard
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

7.  Neoadjuvant Intratumoral Immunotherapy with TLR9 Activation and Anti-OX40 Antibody Eradicates Metastatic Cancer.

Authors:  Wan Xing Hong; Idit Sagiv-Barfi; Debra K Czerwinski; Adrienne Sallets; Ronald Levy
Journal:  Cancer Res       Date:  2022-04-01       Impact factor: 13.312

8.  CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.

Authors:  Wei Huang; Jingyao Zhang; Miaomiao Huo; Jie Gao; Tianshu Yang; Xin Yin; Pei Wang; Shuai Leng; Dandan Feng; Yang Chen; Yang Yang; Yan Wang
Journal:  Adv Sci (Weinh)       Date:  2021-03-16       Impact factor: 16.806

Review 9.  In vivo models in breast cancer research: progress, challenges and future directions.

Authors:  Ingunn Holen; Valerie Speirs; Bethny Morrissey; Karen Blyth
Journal:  Dis Model Mech       Date:  2017-04-01       Impact factor: 5.758

10.  Physical activity delays accumulation of immunosuppressive myeloid-derived suppressor cells.

Authors:  Jacob Garritson; Luke Krynski; Lea Haverbeck; James M Haughian; Nicholas A Pullen; Reid Hayward
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.